Lifeclean Q4’22: First take – roughly in line - Redeye
Redeye saw sales that almost reached our expectations for the quarter. Sales have recovered somewhat since a weak Q3. Opex was very much in line with expectations. PFAS interestingly a large part of the sales in the quarter.
ANNONS
Redeye saw sales that almost reached our expectations for the quarter. Sales have recovered somewhat since a weak Q3. Opex was very much in line with expectations. PFAS interestingly a large part of the sales in the quarter.